OSCR

Glioblastoma cells utilize evolutionarily adapted cell metabolism to promote their malignant proliferation.

Overview

Authors: Maxim M. Bespalov1, Vasiliki Gkini1, Zeynep Iloglu1, Seiya Yamada1, Akira Nemoto1,2, Pauliina Filppu3,4, Kalevi Trontti1, Liliia Andriichuk1, Olli Pietiläinen1, Vadim Le Joncour1,4, Anni I. Nieminen5, Pirjo Laakkonen3,4,6, Takashi Namba1,7,8
  1. Neuroscience Center, HiLIFE—Helsinki Institute of Life Science, University of Helsinki,Helsinki, Finland
  2. Division of Microscopic Anatomy, Graduate School of Medical and Dental Sciences, Niigata University,Niigata, Japan
  3. Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki,Helsinki, Finland
  4. ICAN Digital Precision Medicine Flagship Program, University of Helsinki,Helsinki, Finland
  5. Stem Cell and Metabolism Research Program, Faculty of Medicine, University of Helsinki,Helsinki, Finland
  6. Laboratory Animal Center, HiLIFE—Helsinki Institute of Life Science, University of Helsinki,Helsinki, Finland
  7. Department of Developmental Biology, Fujita Health University School of Medicine,Toyoake, Japan
  8. Division of Developmental Neurobiology, International Center for Brain Science (ICBS), Fujita Health University,Toyoake, Japan
Institutions: University of Helsinki (Finland); Niigata University (Japan); Fujita Health University (Japan)
Journal: Acta neuropathologica communications, volume 14, issue 1, article 146
Dates: received 4 December 2025; accepted 1 May 2026; published online 13 May 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1186/s40478-026-02318-7 · PMID 42129945 · PMCID PMC13348691 · OpenAlex W7161026289
Open access: gold, a free copy (OpenAlex)
Categories: human (organism), other condition (population), cellular / molecular (subfield)
Keywords: Glioblastoma, ARHGAP11B, Glutaminolysis, GOT2, Glutamic-oxaloacetic transaminase, Nucleotide biosynthesis, Mitochondrial metabolism, Metabolic reprogramming, Oncometabolism, Cell proliferation
MeSH: Brain Neoplasms*, Cell Proliferation*, Glioblastoma*, Cell Line, Tumor, Humans, Metabolic Reprogramming, Neural Stem Cells (* major topic)
Topic: Cancer, Hypoxia, and Metabolism (Cancer Research, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Funding: University of Helsinki including Helsinki University Central Hospital
Citations: cited by 1 paper (Europe PMC); 65 references in the paper

Abstract

Glioblastoma is the most aggressive primary brain tumor in adults, with limited therapeutic success and, therefore, poor prognosis. Its malignancy is partly driven by the high proliferative capacity of glioblastoma cells, yet the underlying molecular mechanisms remain unclear. Recent studies have revealed transcriptomic similarities between glioblastoma cells and human fetal neural stem/progenitor cells (NSCs), suggesting that glioblastoma may exploit developmental programs that promote NSC proliferation. Fetal human NSCs rely on glutaminolysis—a metabolic pathway induced by the human-specific mitochondrial protein ARHGAP11B—to sustain proliferation. Here, we show that ARHGAP11B expression correlates with glioma malignancy and is essential for glioblastoma cell proliferation, implicating a critical role of glutaminolysis in tumor growth. Among glutaminolysis-related enzymes, glutamic-oxaloacetic transaminase 2 (GOT2) shows a strong positive correlation with glioma grade and poor patient prognosis. Functional assays reveal that GOT2 knockdown significantly suppresses glioblastoma cell growth, indicating that GOT2-mediated glutaminolysis is critical for their proliferation. Metabolomic profiling further shows that GOT2 is required for nucleotide precursor synthesis, underscoring its role in supporting DNA replication. Consistently, GOT2 depletion reduces the proportion of glioblastoma cells in the S phase of the cell cycle. These findings suggest glioblastoma cells hijack an evolutionarily adapted metabolic program to support malignant growth.

Supplementary Information: The online version contains supplementary material available at 10.1186/s40478-026-02318-7.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Other data links

Data availability

All data are available in the manuscript or the supplementary material, or publicly available as indicated in the Materials and Methods. Glioblastoma cells are available upon reasonable request to PL. Other materials are available upon reasonable request to TN.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 13 authors, 10 keywords, 7 MeSH terms, 1 funder, 64 references.

Cite

This paper

Bespalov, M. M., Gkini, V., Iloglu, Z., Yamada, S., Nemoto, A., Filppu, P., Trontti, K., Andriichuk, L., Pietiläinen, O., Le Joncour, V., Nieminen, A. I., Laakkonen, P., & Namba, T. (2026). Glioblastoma cells utilize evolutionarily adapted cell metabolism to promote their malignant proliferation. Acta neuropathologica communications, 14(1), 146. https://doi.org/10.1186/s40478-026-02318-7

BibTeX

@article{bespalov2026glioblastoma,
author = {Bespalov, Maxim M. and Gkini, Vasiliki and Iloglu, Zeynep and Yamada, Seiya and Nemoto, Akira and Filppu, Pauliina and Trontti, Kalevi and Andriichuk, Liliia and Pietiläinen, Olli and Le Joncour, Vadim and Nieminen, Anni I. and Laakkonen, Pirjo and Namba, Takashi},
title = {{Glioblastoma cells utilize evolutionarily adapted cell metabolism to promote their malignant proliferation}},
journal = {Acta neuropathologica communications},
year = {2026},
month = may,
volume = {14},
number = {1},
pages = {146},
publisher = {BMC},
issn = {2051-5960},
doi = {10.1186/s40478-026-02318-7},
url = {https://doi.org/10.1186/s40478-026-02318-7},
pmid = {42129945},
pmcid = {PMC13348691}
}

RIS

TY - JOUR
AU - Bespalov, Maxim M.
AU - Gkini, Vasiliki
AU - Iloglu, Zeynep
AU - Yamada, Seiya
AU - Nemoto, Akira
AU - Filppu, Pauliina
AU - Trontti, Kalevi
AU - Andriichuk, Liliia
AU - Pietiläinen, Olli
AU - Le Joncour, Vadim
AU - Nieminen, Anni I.
AU - Laakkonen, Pirjo
AU - Namba, Takashi
TI - Glioblastoma cells utilize evolutionarily adapted cell metabolism to promote their malignant proliferation
T2 - Acta neuropathologica communications
J2 - Acta Neuropathol Commun
PY - 2026
DA - 2026/05/13
VL - 14
IS - 1
SP - 146
SN - 2051-5960
PB - BMC
DO - 10.1186/s40478-026-02318-7
UR - https://doi.org/10.1186/s40478-026-02318-7
LA - en
ER -

CSL-JSON

{
"id": "10.1186/s40478-026-02318-7",
"type": "article-journal",
"title": "Glioblastoma cells utilize evolutionarily adapted cell metabolism to promote their malignant proliferation",
"container-title": "Acta neuropathologica communications",
"author": [
{
"family": "Bespalov",
"given": "Maxim M."
},
{
"family": "Gkini",
"given": "Vasiliki"
},
{
"family": "Iloglu",
"given": "Zeynep"
},
{
"family": "Yamada",
"given": "Seiya"
},
{
"family": "Nemoto",
"given": "Akira"
},
{
"family": "Filppu",
"given": "Pauliina"
},
{
"family": "Trontti",
"given": "Kalevi"
},
{
"family": "Andriichuk",
"given": "Liliia"
},
{
"family": "Pietiläinen",
"given": "Olli"
},
{
"family": "Le Joncour",
"given": "Vadim"
},
{
"family": "Nieminen",
"given": "Anni I."
},
{
"family": "Laakkonen",
"given": "Pirjo"
},
{
"family": "Namba",
"given": "Takashi"
}
],
"container-title-short": "Acta Neuropathol Commun",
"volume": "14",
"issue": "1",
"page": "146",
"DOI": "10.1186/s40478-026-02318-7",
"PMID": "42129945",
"PMCID": "PMC13348691",
"ISSN": "2051-5960",
"publisher": "BMC",
"URL": "https://doi.org/10.1186/s40478-026-02318-7",
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
13
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1002/advs.202509590
Therapeutic Reprogramming of Glioblastoma Phenotypic States Using Multifunctional Heparin Nanoparticles.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
In common: other condition, 5 references, 2 authors
[2] doi:10.1007/s00702-022-02570-w
Embryonic mouse medial neocortex as a model system for studying the radial glial scaffold in fetal human neocortex.
Journal: Journal of neural transmission (Vienna, Austria : 1996)
In common: 7 references, author Takashi Namba
[3] doi:10.1038/s44318-024-00068-7
The growth factor EPIREGULIN promotes basal progenitor cell proliferation in the developing neocortex.
Journal: The EMBO journal
In common: cellular / molecular, 8 references
[4] doi:10.1016/j.isci.2021.103484
Drp1 SUMO/deSUMOylation by Senp5 isoforms influences ER tubulation and mitochondrial dynamics to regulate brain development.
Journal: iScience
In common: cellular / molecular, 2 references, author Seiya Yamada
[5] doi:10.1038/s42003-026-10802-y
Transcriptome of fetal cortex of tree shrew underlying the emergence of outer subventricular zone.
Journal: Communications biology
In common: 6 references
[6] doi:10.1016/j.neuron.2022.10.018
CROCCP2 acts as a human-specific modifier of cilia dynamics and mTOR signaling to promote expansion of cortical progenitors.
Journal: Neuron
In common: 6 references
[7] doi:10.1038/s41559-022-01925-6 [code]
De novo genes with an lncRNA origin encode unique human brain developmental functionality.
Journal: Nature ecology & evolution
In common: 6 references
[8] doi:10.1186/s40478-023-01613-x
Decoding key cell sub-populations and molecular alterations in glioblastoma at recurrence by single-cell analysis.
Journal: Acta neuropathologica communications
In common: other condition, cellular / molecular, 7 references
[9] doi:10.1038/s41467-023-38186-1 [code]
Re-convolving the compositional landscape of primary and recurrent glioblastoma reveals prognostic and targetable tissue states.
Journal: Nature communications
In common: other condition, 6 references
[10] doi:10.7554/elife.83593 [code]
Regulatory and coding sequences of TRNP1 co-evolve with brain size and cortical folding in mammals.
Journal: eLife
In common: cellular / molecular, 5 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.